Page last updated: 2024-10-24

response to oxygen levels

Definition

Target type: biologicalprocess

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting the presence, absence, or concentration of oxygen. [GOC:BHF, GOC:mah]

Response to oxygen levels is a fundamental biological process that allows organisms to adapt to fluctuations in oxygen availability. Oxygen is essential for cellular respiration, the process that generates energy (ATP) from glucose. However, excessive oxygen can be damaging, generating reactive oxygen species (ROS) that can lead to oxidative stress and cellular damage. Therefore, organisms have evolved sophisticated mechanisms to sense and respond to changes in oxygen levels.

The response to oxygen levels involves multiple regulatory pathways and cellular components, including:

**Oxygen Sensing:**
- **Hypoxia-Inducible Factor (HIF):** This transcription factor is a key regulator of the cellular response to low oxygen (hypoxia). HIF is composed of two subunits, HIF-α and HIF-β. Under normoxic conditions, HIF-α is rapidly degraded by the proteasome. However, under hypoxic conditions, HIF-α is stabilized and translocates to the nucleus, where it forms a heterodimer with HIF-β and binds to hypoxia response elements (HREs) in the promoter regions of target genes.

- **Other Oxygen Sensors:** While HIF is the most well-studied oxygen sensor, other molecules and mechanisms also contribute to oxygen sensing, including:
- **Prolyl hydroxylase domain (PHD) enzymes:** These enzymes hydroxylate HIF-α, targeting it for degradation.
- **Other transcription factors:** Factors like nuclear respiratory factor 1 (NRF1) and NRF2 can also be activated in response to low oxygen.

**Cellular Adaptations:**
- **Increased Erythropoiesis:** HIF stimulates the production of red blood cells (erythrocytes) to increase oxygen carrying capacity.
- **Vascular Remodeling:** HIF promotes angiogenesis (formation of new blood vessels) and vasodilation to improve oxygen delivery to tissues.
- **Metabolic Switching:** Cells switch to anaerobic metabolism (glycolysis) to generate energy in the absence of sufficient oxygen.
- **Cellular Proliferation and Differentiation:** HIF can influence cell growth and development under low oxygen conditions.
- **Immune Response:** Oxygen levels can influence immune cell function and inflammatory responses.

**Regulation and Feedback:**
- **Oxygen-dependent Degradation:** HIF-α is rapidly degraded under normoxic conditions, ensuring a rapid response to changes in oxygen levels.
- **Post-translational Modifications:** HIF is regulated by various post-translational modifications, including phosphorylation and acetylation.
- **MicroRNA-mediated regulation:** MicroRNAs (miRNAs) can regulate the expression of HIF target genes.

**Pathological Implications:**
- **Cancer:** HIF is often overexpressed in cancer cells, contributing to tumor growth and metastasis.
- **Ischemia:** HIF plays a role in tissue damage during ischemia (reduced blood flow).
- **Chronic Diseases:** Disruptions in oxygen sensing and response can contribute to various chronic diseases, including cardiovascular disease, diabetes, and neurodegenerative diseases.

**Applications:**
- **Drug Development:** HIF inhibitors are being developed as potential cancer therapies.
- **Tissue Engineering:** Understanding oxygen sensing is crucial for developing effective strategies for tissue engineering and regenerative medicine.
- **Environmental Monitoring:** Oxygen sensing technologies are used to monitor environmental conditions and assess pollution levels.'
"

Proteins (4)

ProteinDefinitionTaxonomy
Guanylate cyclase soluble subunit beta-1A guanylate cyclase soluble subunit beta-1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q02153]Homo sapiens (human)
Guanylate cyclase soluble subunit beta-2A guanylate cyclase soluble subunit beta-2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O75343]Homo sapiens (human)
Guanylate cyclase soluble subunit alpha-2A guanylate cyclase soluble subunit alpha-2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P33402]Homo sapiens (human)
Guanylate cyclase soluble subunit alpha-1A guanylate cyclase soluble subunit alpha-1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q02108]Homo sapiens (human)

Compounds (5)

CompoundDefinitionClassesRoles
gemfibrozilaromatic etherantilipemic drug
6-anilino-5,8-quinolinedione6-anilino-5,8-quinolinedione : A quinolone that is quinoline-5,8-dione in which the hydrogen at position 6 is replaced by an anilino group.

6-anilino-5,8-quinolinedione: structure given in first source; SRS-A & guanylate cyclase antagonist
aminoquinoline;
aromatic amine;
p-quinones;
quinolone
antineoplastic agent;
EC 4.6.1.2 (guanylate cyclase) inhibitor
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole: antineoplastic; activates platelet guanylate cyclase; a radiosensitizing agent and guanylate cyclase activator; structure in first source

lificiguat : A member of the class of indazoles that is 1H-indazole which is substituted by a benzyl group at position 1 and a 5-(hydroxymethyl)-2-furyl group at position 3. It is an activator of soluble guanylate cyclase and inhibits platelet aggregation.
aromatic primary alcohol;
furans;
indazoles
antineoplastic agent;
apoptosis inducer;
platelet aggregation inhibitor;
soluble guanylate cyclase activator;
vasodilator agent
benzydaminebenzydamine : A member of the class of indazoles carrying benzyl and 3-(dimethylamino)propyl groups at positions 1 and 3 respectively. A locally-acting nonsteroidal anti-inflammatory drug that also exhibits local anaesthetic and analgesic properties.

Benzydamine: A benzyl-indazole having analgesic, antipyretic, and anti-inflammatory effects. It is used to reduce post-surgical and post-traumatic pain and edema and to promote healing. It is also used topically in treatment of RHEUMATIC DISEASES and INFLAMMATION of the mouth and throat.
aromatic ether;
indazoles;
tertiary amino compound
analgesic;
central nervous system stimulant;
hallucinogen;
local anaesthetic;
non-steroidal anti-inflammatory drug
bay 41-8543BAY 41-8543: structure in first sourcepyrazolopyridine